본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

한국형 우울장애 약물치료 알고리듬 2021 (IV)

이용수 48

영문명
Korean Medication Algorithm Project for Depressive Disorder 2021 (IV): Female and Elderly
발행기관
대한신경정신의학회
저자명
왕성민(Sheng-Min Wang) 박원명(Won-Myong Bahk) 우영섭(Young Sup Woo) 서정석(Jeong Seok Seo) 박영민(Young-Min Park)
간행물 정보
『신경정신의학』제60권 제4호, 258~266쪽, 전체 9쪽
주제분류
의약학 > 정신과학
파일형태
PDF
발행일자
2021.11.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Objectives An expert consensus guideline for the treatment of depressive disorder, the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD), was first established in 2002 and updated in 2017. To provide an up-to-date treatment guideline, KMAP-DD 2021 was recently completed. This study was undertaken to provide a guideline for the treatment of depressive disorder in a selected population that included females and elderly. Methods The survey conducted consisted of 7 questionnaires for each population, females and elderly, with depressive disorder. A total of 65 of 97 experienced psychiatrists answered the survey. Results For the treatment of premenstrual dysphoric disorder, the selective serotonin reuptake inhibitors, venlafaxine, and desvenlafaxine were recommended as first-line therapies. For major depressive disorder (MDD) during pregnancy, antidepressant (AD) monotherapy was recommended as a first-line therapy for mild to moderate and severe depression, and combined electroconvulsive therapy and AD with atypical antipsychotics (AAP) were recommended as a first-line therapy for severe depression with psychotic features. AD plus AAP was generally recommended for post-partum depression. In elderly with depression, AD monotherapy was recommended as the treatment of choice for mild to moderate episodes, and AD monotherapy and AD plus AAP were recommended as a first-line therapy for severe depression without psychotic features. Lastly, AD plus AAP was chosen as the treatment of choice for psychotic depression. Conclusion Present study provides an updated algorithm for the treatment of females and elderly with depressive disorders. This algorithm provides a practical aid to clinicians for the treatment of females and elderly with MDD.

목차

서 론
방 법
결 과
고 찰
결 론

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

왕성민(Sheng-Min Wang),박원명(Won-Myong Bahk),우영섭(Young Sup Woo),서정석(Jeong Seok Seo),박영민(Young-Min Park),김. (2021).한국형 우울장애 약물치료 알고리듬 2021 (IV). 신경정신의학, 60 (4), 258-266

MLA

왕성민(Sheng-Min Wang),박원명(Won-Myong Bahk),우영섭(Young Sup Woo),서정석(Jeong Seok Seo),박영민(Young-Min Park),김. "한국형 우울장애 약물치료 알고리듬 2021 (IV)." 신경정신의학, 60.4(2021): 258-266

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제